From Moderna’s trial results to Covaxin’s immunity booster: Covid-19 vaccine latest developments | Latest News India - Hindustan Times
close_game
close_game

From Moderna’s trial results to Covaxin’s immunity booster: Covid-19 vaccine latest developments

Hindustan Times, New Delhi | Byhindustantimes.com| Edited by Susmita Pakrasi
Oct 07, 2020 06:26 PM IST

India’s Covid-19 case count rose to 67.57 lakh with 72,049 new cases in a day, while 57,44,693 people have recovered so far pushing the national recovery rate to 85.02%, according to the Union Health Ministry data on Wednesday.

Drugmakers and research centres around the world are working on Covid-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants underway.

The Covid-19 case mortality rate has further declined to 1.55%.(AP)
The Covid-19 case mortality rate has further declined to 1.55%.(AP)

Some companies are close to unveiling their initial findings - Canadian and European regulators have already reviewed early data on some vaccines to help end the coronavirus pandemic that has claimed over a million lives.

Hindustan Times - your fastest source for breaking news! Read now.

India’s Covid-19 case count rose to 67.57 lakh with 72,049 new cases in a day, while 57,44,693 people have recovered so far pushing the national recovery rate to 85.02%, according to the Union health ministry on Wednesday.

The total coronavirus cases rose to 67,57,131, while the death count climbed to 1,04,555 with the coronavirus killing 986 lives in the last 24 hours in the country, the data showed. The Covid-19 case mortality rate has further declined to 1.55%.

Here are all the latest updates on Covid-19 vaccine:

1. A phase 1 investigational trial has revealed that the Covid-19 vaccine developed by US-based pharmaceutical company Moderna elicited a strong immune response in older adults with no serious adverse effects, a study has claimed.

2. In India, an expert panel of Drugs Controller General (DCGI) has directed pharma giant Dr Reddy’s Laboratories to submit a revised protocol for performing phase 2 and 3 clinical trials of the Russian Covid-19 vaccine (Sputnik V) in India, news agency ANI quoted a government official as saying.

3. Vaccine major Bharat Biotech on Monday announced its Covid-19 vaccine Covaxin will use adjuvant Alhydroxiquim-II to boost immune response. An adjuvant is a pharmacological or immunological agent that improves the immune response of a vaccine by producing more antibodies and providing longer-lasting immunity.

4. The Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership to develop vaccines against emerging infectious diseases, has partnered with the Faridabad-based Translational Health Sciences and Research Institute (THSTI) as one of the five laboratories that will create a global network for reliably assessing all vaccines against the coronavirus disease (Covid-19).

5. The Union health ministry, meanwhile, said on Tuesday that it was expecting Covid-19 vaccine supplies to be available from early next year. Addressing a press conference, health secretary Rajesh Bhushan said: “If all goes well, we are looking at vaccine supplies coming in the first quarter of next year.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On